NO20085414L - Farmasoytiske preparater for vedvarende frigivelse av fenylefrin - Google Patents
Farmasoytiske preparater for vedvarende frigivelse av fenylefrinInfo
- Publication number
- NO20085414L NO20085414L NO20085414A NO20085414A NO20085414L NO 20085414 L NO20085414 L NO 20085414L NO 20085414 A NO20085414 A NO 20085414A NO 20085414 A NO20085414 A NO 20085414A NO 20085414 L NO20085414 L NO 20085414L
- Authority
- NO
- Norway
- Prior art keywords
- phenylephrine
- sustained release
- pharmaceutical preparations
- dosage form
- solid dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen beskriver et farmasøytisk preparat omfattende fenylefrin i en formulering med vedvarende frigivelse, alene eller i kombinasjon med annet aktivt middel slik som et antihistamin, et analgetisk middel, et antipyretisk middel eller et ikke-steroidalt, antiinflammatorisk middel eller en blanding av to eller flere aktive midler. I en foretrukket utførelsesform omfatter preparatet en fast doseringsform med hydroksypropylmetylcellulose og karboksymetylcellulosenatrium som en matriks for vedvarende frigivelse av fenylefrin. Fenylefrin frigis over en forlenget tidsperiode av den faste doseringsform hovedsakelig uavhengig av pH.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81001906P | 2006-06-01 | 2006-06-01 | |
PCT/US2007/013056 WO2007143163A2 (en) | 2006-06-01 | 2007-06-01 | Pharmaceutical compositions for sustained release of phenyephrine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085414L true NO20085414L (no) | 2008-12-30 |
Family
ID=38565616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085414A NO20085414L (no) | 2006-06-01 | 2008-12-30 | Farmasoytiske preparater for vedvarende frigivelse av fenylefrin |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070281020A1 (no) |
EP (1) | EP2029114B1 (no) |
JP (1) | JP5121824B2 (no) |
KR (1) | KR101464771B1 (no) |
CN (2) | CN104606163A (no) |
AR (1) | AR061166A1 (no) |
AU (1) | AU2007254826B2 (no) |
BR (1) | BRPI0711871A2 (no) |
CA (1) | CA2653955C (no) |
MX (1) | MX2008015358A (no) |
NO (1) | NO20085414L (no) |
PE (3) | PE20150773A1 (no) |
RU (1) | RU2450803C2 (no) |
SG (1) | SG172660A1 (no) |
TW (1) | TWI405567B (no) |
WO (1) | WO2007143163A2 (no) |
ZA (1) | ZA200810178B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010014952A2 (en) | 2008-07-31 | 2010-02-04 | Clarke Mosquito Control Products, Inc. | Extended release tablet and method for making and using same |
TWI394594B (zh) * | 2009-03-06 | 2013-05-01 | China Chemical & Pharmaceutical Co Ltd | 錠劑藥學組成物及其製造方法 |
US20110104272A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
US20110104273A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
WO2011121475A2 (en) * | 2010-03-31 | 2011-10-06 | Wockhardt Limited | Modified release dosage form comprising desvenlafaxine or salts thereof |
US20140271893A1 (en) | 2013-03-15 | 2014-09-18 | Mcneil-Ppc, Inc. | Coated phenylephrine particles and use thereof in pharmaceutical formulations |
US20140271891A1 (en) | 2013-03-15 | 2014-09-18 | Mcneil-Ppc, Inc. | Phenylephrine resinate particles and use thereof in pharmaceutical formulations |
US9795571B2 (en) | 2014-09-19 | 2017-10-24 | The Procter & Gamble Company | Pulsed release phenylephrine dosage forms |
MA41152A (fr) | 2014-12-12 | 2017-10-17 | Johnson & Johnson Consumer Inc | Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
US3558768A (en) * | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
JPS61501205A (ja) * | 1984-02-15 | 1986-06-19 | シェリング・コ−ポレ−ション | 8↓−クロル↓−6,11↓−ジヒドロ↓−11↓−(4↓−ピペリジリデン)↓−5H↓−ベンゾ〔5,6〕シクロヘプタ〔1,2−b〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物 |
US5025019A (en) * | 1984-04-09 | 1991-06-18 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
US4623664A (en) * | 1985-10-31 | 1986-11-18 | University Of Iowa Research Foundation | Oil suspended phenylephrine |
US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
US4816264A (en) * | 1986-06-06 | 1989-03-28 | Warner-Lambert Company | Sustained release formulations |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US5085865A (en) * | 1989-04-12 | 1992-02-04 | Warner-Lambert Company | Sustained release pharmaceutical preparations containing an analgesic and a decongestant |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
FR2655266B1 (fr) * | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
IT1246188B (it) * | 1990-07-27 | 1994-11-16 | Resa Farma | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. |
EP0542926B1 (en) * | 1990-08-07 | 1995-02-15 | Pfizer Inc. | Use of interfacially-polymerized membranes in delivery devices |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US6160020A (en) * | 1996-12-20 | 2000-12-12 | Mcneill-Ppc, Inc. | Alkali metal and alkaline-earth metal salts of acetaminophen |
MX9701946A (es) * | 1997-03-14 | 1998-04-30 | Arturo Jimenez Bayardo | Solucion oftalmica transportadora. |
DE69833000T2 (de) * | 1997-09-26 | 2006-09-07 | Noven Pharmaceuticals, Inc., Miami | Bio-klebemittelzusammensetzungen |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US6521254B2 (en) * | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
US6114346A (en) * | 1999-10-22 | 2000-09-05 | Schering Corporation | Treating sleep disorders using desloratadine |
AU2276801A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
AU2277101A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Stable extended release oral dosage composition |
US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
AU2001261744A1 (en) * | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
US20030236275A1 (en) * | 2002-06-20 | 2003-12-25 | Schering Corporation | Treatment methods of nasal congestion and nasal obstruction |
US7163696B2 (en) * | 2001-10-11 | 2007-01-16 | Pfizer Inc. | Pharmaceutical formulations |
US20030083354A1 (en) * | 2001-10-26 | 2003-05-01 | Pediamed Pharmaceuticals, Inc. | Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions |
US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
US20030114535A1 (en) * | 2001-12-14 | 2003-06-19 | Jame Fine Chemicals, Inc. | Dextrochlorpheniramine tannate |
KR100540035B1 (ko) * | 2002-02-01 | 2005-12-29 | 주식회사 태평양 | 다단계 경구 약물 방출 제어 시스템 |
US20030203027A1 (en) * | 2002-04-26 | 2003-10-30 | Ethicon, Inc. | Coating technique for deposition of drug substance on a substrate |
US20040253311A1 (en) * | 2002-12-18 | 2004-12-16 | Roger Berlin | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines |
US6979689B2 (en) * | 2002-12-20 | 2005-12-27 | Pediamed Pharmaceuticals, Inc. | Compositions and methods for treating upper respiratory congestion |
US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
US20050152967A1 (en) * | 2003-03-28 | 2005-07-14 | Pfab, Lp | Dynamic variable release |
US20050026890A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease |
US20050095288A1 (en) * | 2003-11-03 | 2005-05-05 | Andrx Labs, Llc | Decongestant and expectorant tablets |
US9492541B2 (en) * | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
EP1874275A1 (en) * | 2004-12-13 | 2008-01-09 | McNEIL-PPC, INC. | Compositons and methods for stabilizing active pharmaceutical ingredients |
US8940796B2 (en) * | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
US20080014274A1 (en) * | 2006-07-14 | 2008-01-17 | Wyeth | Enhanced stability phenylephrine liquid compositions |
US9005652B2 (en) * | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
US7378082B1 (en) * | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
-
2007
- 2007-06-01 TW TW096119767A patent/TWI405567B/zh active
- 2007-06-01 JP JP2009513322A patent/JP5121824B2/ja active Active
- 2007-06-01 CN CN201510086942.0A patent/CN104606163A/zh active Pending
- 2007-06-01 BR BRPI0711871-6A patent/BRPI0711871A2/pt not_active IP Right Cessation
- 2007-06-01 CN CNA2007800277845A patent/CN101505735A/zh active Pending
- 2007-06-01 PE PE2015000135A patent/PE20150773A1/es not_active Application Discontinuation
- 2007-06-01 KR KR1020087031377A patent/KR101464771B1/ko active IP Right Grant
- 2007-06-01 EP EP07795663.9A patent/EP2029114B1/en active Active
- 2007-06-01 SG SG2011039831A patent/SG172660A1/en unknown
- 2007-06-01 WO PCT/US2007/013056 patent/WO2007143163A2/en active Application Filing
- 2007-06-01 CA CA2653955A patent/CA2653955C/en active Active
- 2007-06-01 PE PE2007000686A patent/PE20080330A1/es not_active Application Discontinuation
- 2007-06-01 RU RU2008151946/15A patent/RU2450803C2/ru active
- 2007-06-01 AR ARP070102384A patent/AR061166A1/es not_active Application Discontinuation
- 2007-06-01 MX MX2008015358A patent/MX2008015358A/es active IP Right Grant
- 2007-06-01 US US11/756,774 patent/US20070281020A1/en not_active Abandoned
- 2007-06-01 AU AU2007254826A patent/AU2007254826B2/en active Active
- 2007-06-01 PE PE2011001106A patent/PE20120075A1/es not_active Application Discontinuation
-
2008
- 2008-11-28 ZA ZA2008/10178A patent/ZA200810178B/en unknown
- 2008-12-30 NO NO20085414A patent/NO20085414L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TWI405567B (zh) | 2013-08-21 |
CA2653955C (en) | 2015-10-27 |
TW200804235A (en) | 2008-01-16 |
AR061166A1 (es) | 2008-08-06 |
RU2008151946A (ru) | 2010-07-20 |
ZA200810178B (en) | 2009-12-30 |
SG172660A1 (en) | 2011-07-28 |
BRPI0711871A2 (pt) | 2011-12-06 |
CN101505735A (zh) | 2009-08-12 |
KR101464771B1 (ko) | 2014-11-26 |
PE20080330A1 (es) | 2008-04-25 |
JP5121824B2 (ja) | 2013-01-16 |
PE20120075A1 (es) | 2012-02-20 |
EP2029114B1 (en) | 2014-09-24 |
RU2450803C2 (ru) | 2012-05-20 |
WO2007143163A3 (en) | 2008-07-24 |
CN104606163A (zh) | 2015-05-13 |
MX2008015358A (es) | 2009-03-06 |
PE20150773A1 (es) | 2015-05-21 |
EP2029114A2 (en) | 2009-03-04 |
AU2007254826A1 (en) | 2007-12-13 |
AU2007254826B2 (en) | 2013-10-24 |
CA2653955A1 (en) | 2007-12-13 |
JP2009538921A (ja) | 2009-11-12 |
US20070281020A1 (en) | 2007-12-06 |
KR20090015990A (ko) | 2009-02-12 |
WO2007143163A2 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085414L (no) | Farmasoytiske preparater for vedvarende frigivelse av fenylefrin | |
ECSP17013617A (es) | combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
NO20083104L (no) | Fast preparat | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
DOP2006000241A (es) | Composiciones farmacéuticas sólidas que contienen pregabalina | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
GT200600096A (es) | Composicion farmaceutica para el tratamiento del cancer | |
CY1109719T1 (el) | Σκευασμα 1-[(3-υδροξυ-αδαμαντ-1-υλαμινο)-ακετυλο]-πυρρολιδινο-2-(s)-καρβονιτριλιου τροποποιημενης απελευθερωσης | |
RS51304B (sr) | Farmaceutske kompozicije neuroaktivnog steroida i njihova upotreba | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
NO20081790L (no) | Topiske formuleringer | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
ECSP099348A (es) | Composición farmacéutica de liberación modificada de un músculo relajante y un aine | |
AR066924A1 (es) | Formulacion de nevirapina de liberacion prolongada | |
UY30126A1 (es) | Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones | |
CL2011001207A1 (es) | Extruidos que contienen al menos una sustancia farmacéuticamente activa en forma de agujas, tal que la relación entre el tamaño de partículas de la sustancia farmacéuticamente activa con forma de agujas y el diámetro de la cadena es de al menos 1:20; composición farmacéutica; y su uso para preparar medicamentos. | |
Marshall et al. | Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood | |
AR059081A1 (es) | Composicion farmaceutica estable de carisoprodol y meloxicam | |
RS53095B (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS OF KETOPROPHEN AND METHYLSULPHONYLMETHANE | |
NO20084711L (no) | Nytt synergistisk, farmasoytisk preparat | |
CL2007001944A1 (es) | Compuestos derivados de 5-bencil-pirazol; composicion farmaceutica que comprende a dichos compuestos; y el uso de los compuestos para reforzar la exposicion farmacocinetica de farmacos administrados metabolizados por la enzima cip450 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: MERCK SHARP AND DOHME CORP, US Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |